Perfil
James Wooldridge is currently the Chief Medical Officer at Checkmate Pharmaceuticals, Inc. He previously worked as the Chief Medical Officer at Spyre Therapeutics, Inc. from 2017 to 2019 and as the Chief Scientific Officer at Eli Lilly & Co. He received his doctorate degree from Tulane University in 1992 and his undergraduate degree from William Jewell College in 1988.
Cargos activos de James Wooldridge
| Empresas | Cargo | Inicio |
|---|---|---|
| CHECKMATE PHARMACEUTICALS, INC. | Director Técnico/Científico/I+D | 01/10/2019 |
Antiguos cargos conocidos de James Wooldridge.
| Empresas | Cargo | Fin |
|---|---|---|
| SPYRE THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 10/10/2019 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
Formación de James Wooldridge.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
Eli Lilly & Co.
Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Spyre Therapeutics, Inc.
Spyre Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
Tulane University (Louisiana)
Tulane University (Louisiana) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
William Jewell College
William Jewell College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Checkmate Pharmaceuticals, Inc.
Checkmate Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develop anti-cancer therapeutics | Health Technology |
- Bolsa de valores
- Insiders
- James Wooldridge
















